MAFLD, formerly known as non-alcoholic fatty liver disease (NAFLD), shares several pathophysiological mechanisms with ALD but is mainly driven by metabolic imbalances, including excess caloric intake, insulin resistance, and altered adipose tissue function. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.